New York S 6629: Relates to providing transparency in the retail prices of prescription drugs

Status: REFERRED TO RULES (as of 2017-06-08)

State: New York · Session: 2017-2018 · Bill: S 6629

Sponsors: LATIMER

View New York S 6629 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.